| Product Code: ETC9694730 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Secukinumab Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Secukinumab Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Secukinumab Market - Industry Life Cycle |
3.4 Thailand Secukinumab Market - Porter's Five Forces |
3.5 Thailand Secukinumab Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Thailand Secukinumab Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Thailand Secukinumab Market Revenues & Volume Share, By Demographic, 2021 & 2031F |
3.8 Thailand Secukinumab Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 Thailand Secukinumab Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Thailand Secukinumab Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Thailand Secukinumab Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of autoimmune diseases in Thailand |
4.2.2 Growing awareness about the effectiveness of secukinumab in treating psoriasis and other autoimmune conditions |
4.2.3 Rising healthcare expenditure and improved access to advanced treatments in Thailand |
4.3 Market Restraints |
4.3.1 High cost of secukinumab compared to alternative treatment options |
4.3.2 Stringent regulatory requirements for approval and reimbursement of secukinumab |
4.3.3 Limited availability of healthcare professionals trained in prescribing and administering secukinumab in Thailand |
5 Thailand Secukinumab Market Trends |
6 Thailand Secukinumab Market, By Types |
6.1 Thailand Secukinumab Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Thailand Secukinumab Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Thailand Secukinumab Market Revenues & Volume, By Sensoready Pen, 2021- 2031F |
6.1.4 Thailand Secukinumab Market Revenues & Volume, By Prefilled Syringe, 2021- 2031F |
6.1.5 Thailand Secukinumab Market Revenues & Volume, By Powder for Solution, 2021- 2031F |
6.2 Thailand Secukinumab Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Thailand Secukinumab Market Revenues & Volume, By Interleukin Inhibitors, 2021- 2031F |
6.2.3 Thailand Secukinumab Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Thailand Secukinumab Market, By Demographic |
6.3.1 Overview and Analysis |
6.3.2 Thailand Secukinumab Market Revenues & Volume, By Adult, 2021- 2031F |
6.3.3 Thailand Secukinumab Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.4 Thailand Secukinumab Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Thailand Secukinumab Market Revenues & Volume, By Ankylosing Spondylitis, 2021- 2031F |
6.4.3 Thailand Secukinumab Market Revenues & Volume, By Psoriatic Arthritis, 2021- 2031F |
6.4.4 Thailand Secukinumab Market Revenues & Volume, By Plaque Psoriasis, 2021- 2031F |
6.4.5 Thailand Secukinumab Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Thailand Secukinumab Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Thailand Secukinumab Market Revenues & Volume, By Clinic, 2021- 2031F |
6.5.3 Thailand Secukinumab Market Revenues & Volume, By Hospital, 2021- 2031F |
6.5.4 Thailand Secukinumab Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Thailand Secukinumab Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Thailand Secukinumab Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Thailand Secukinumab Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Thailand Secukinumab Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Thailand Secukinumab Market Import-Export Trade Statistics |
7.1 Thailand Secukinumab Market Export to Major Countries |
7.2 Thailand Secukinumab Market Imports from Major Countries |
8 Thailand Secukinumab Market Key Performance Indicators |
8.1 Number of patients switching to secukinumab from traditional treatments |
8.2 Rate of adoption of secukinumab by healthcare facilities and clinics |
8.3 Patient satisfaction and adherence rates with secukinumab treatment |
8.4 Number of clinical trials and research studies on secukinumab conducted in Thailand |
8.5 Percentage of healthcare professionals attending training programs on secukinumab |
9 Thailand Secukinumab Market - Opportunity Assessment |
9.1 Thailand Secukinumab Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Thailand Secukinumab Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Thailand Secukinumab Market Opportunity Assessment, By Demographic, 2021 & 2031F |
9.4 Thailand Secukinumab Market Opportunity Assessment, By Application, 2021 & 2031F |
9.5 Thailand Secukinumab Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Thailand Secukinumab Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Thailand Secukinumab Market - Competitive Landscape |
10.1 Thailand Secukinumab Market Revenue Share, By Companies, 2024 |
10.2 Thailand Secukinumab Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here